SCHEMBL24591606

SCHEMBL24591606

Nc1ncnc2c([C@H]3C[C@@]4(O)C(O)[C@@]4(CCl)O3)csc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21880480 1.00 — —
SCHEMBL19962233 0.89 HIF1A (0.32) —
SCHEMBL19644659 0.77 HIF1A (0.32) —
SCHEMBL19644661 0.77 HIF1A (0.32) —
SCHEMBL24591619 0.76 — —
SCHEMBL19962846 0.74 HIF1A (0.32) —
SCHEMBL24591618 0.73 HIF1A (0.30) —
SCHEMBL21137368 0.73 HIF1A (0.33) —
SCHEMBL21137374 0.73 HIF1A (0.33) —
SCHEMBL24591624 0.72 HIF1A (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4023650-A1 4'-SUBSTITUTED-FURO[3,2-D]PYRIMIDINE AND -PYRROLO[3,2- D]PYRIMIDINE DERIVATIVES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2022-07-06 — — EP disclosed
Send feedback